Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Beta Bionics, Inc. - Common Stock
(NQ:
BBNX
)
9.620
-0.010 (-0.10%)
Streaming Delayed Price
Updated: 12:25 PM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Beta Bionics, Inc. - Common Stock
< Previous
1
2
Next >
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
↗
May 13, 2026
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company’s first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales...
Via
MarketBeat
Beta Bionics BBNX Q1 2026 Earnings Transcript
↗
April 21, 2026
Beta Bionics BBNX Q1 2026 Earnings Transcript
Via
The Motley Fool
Beta Bionics Inc (NASDAQ:BBNX) Beats Q1 2026 Estimates and Raises Full-Year Guidance
↗
April 21, 2026
Via
Chartmill
Beta Bionics (BBNX) Q4 2025 Earnings Transcript
↗
February 17, 2026
Beta Bionics (BBNX) Q4 2025 Earnings Transcript
Via
The Motley Fool
Beta Bionics Inc (NASDAQ:BBNX) Reports Q4 Earnings Beat and Provides 2026 Revenue Guidance
↗
February 17, 2026
Via
Chartmill
Topics
Earnings
Earnings Scheduled For October 28, 2025
↗
October 28, 2025
Via
Benzinga
What's going on in today's session
↗
January 09, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
January 09, 2026
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
January 09, 2026
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
January 09, 2026
Via
Chartmill
Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock
↗
July 30, 2025
Via
Benzinga
Earnings Scheduled For July 29, 2025
↗
July 29, 2025
Via
Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
January 08, 2026
Via
Chartmill
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep?
↗
November 10, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
October 29, 2025
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Beta Bionics (BBNX) Q3 2025 Earnings Transcript
↗
October 29, 2025
Beta Bionics (BBNX) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
Earnings
Supply Chain
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 29, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
October 28, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Beta Bionics Inc (NASDAQ:BBNX) Tops Q3 2025 Revenue Estimates and Raises Full-Year Guidance
↗
October 28, 2025
Beta Bionics (BBNX) beat Q3 2025 revenue estimates and raised its full-year guidance. The medical device company reported strong user growth and a narrower-than-expected loss.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 28, 2025
Via
Benzinga
Demystifying Beta Bionics: Insights From 5 Analyst Reviews
↗
October 21, 2025
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Beta Bionics
↗
October 01, 2025
Via
Benzinga
Beta Bionics (BBNX) Q2 Revenue Soars 54%
↗
July 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
Beta Bionics BBNX Q2 2025 Earnings Call Transcript
↗
July 30, 2025
Via
The Motley Fool
Topics
Earnings
Beta Bionics Inc (NASDAQ:BBNX) Surpasses Q2 2025 Estimates and Raises Full-Year Guidance
↗
July 29, 2025
Beta Bionics (BBNX) beats Q2 2025 revenue and EPS estimates, raises full-year guidance. Shares surge 5.7% as iLet Bionic Pancreas and new insulin pump drive growth.
Via
Chartmill
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns
↗
July 03, 2025
Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 03, 2025
Via
Benzinga
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
↗
June 02, 2025
Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.
Via
Benzinga
Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral
↗
May 30, 2025
Wolfe Research initiated coverage with an ‘Outperform’ rating and a $20 target, while Goldman Sachs started at ‘Neutral’ with a $16 target, citing balanced growth prospects and valuation.
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 07, 2025
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
